Amgen Inc. (0R0T.IL)
| Previous close | 308.75 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 8,967 |
| Market cap | 167.855B |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | 20.64 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 8.52 (3.04%) |
| Ex-dividend date | 17 Aug 2023 |
| 1y target est | N/A |
- Zacks
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- Insider Monkey
The Biggest Biotechnology Company in Europe
We’ve recently covered a list of 20 Biggest Publicly-Traded Biotech Companies based on market caps that you can visit here. Biotechnology and Industry 2023: Market Growth, Transformations, and Technological Milestones The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, reaching a staggering $3.88 trillion by 2030. The […]
- Insider Monkey
The Biggest Publicly Traded Biotech Company
In this article, we will be discussing the biggest publicly traded biotech company that ranks at the top of our free list of the 20 Biggest Publicly Traded Biotech Companies. Biotechnology and Industry 2023: Market Growth, Transformations, and Technological Milestones The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate […]
